待补充
[37]. Fanbin Zeng, Cheng Chen, Zhanwei Fu, Haihui Huang, Wenqiang Cui, Yuanyuan Zhou, Yanjie Kong, Xia Liu, Zhiru Xu, et al., A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression, Cellular Oncology, 2025, 48(6), 1821-1836.
[36]. Yuzheng Wu, Xiaoxue Ren, Dezhi Xiao, Pei Liu, You Ke, Wenqiang Cui, Paul K. Chu, Huaiyu Wang, Sacrificing Knight for Pawn‐Queen Promotion: Sonosensitive Nano‐Xanthiums Orchestrate NO to Retain H2O2 for Antibiofilm Therapy, Advanced Materials, 2025, e21809.
[35]. R. Chitsazi, Y. Wu, GPCR Dock 2021 participants, R. C. Stevens, S. Zhao, et al., The 4th GPCR Dock: assessment of blind predictions for GPCR-ligand complexes in the era of AlphaFold, bioRxiv, 2025, 2025.04.18.647407.
[34]. Qianwei Qu, Zhan Zhu, Meiying Zhao, Haifeng Wang, Wenqiang Cui, Xingyu Huang, Zhigang Yuan, Yuting Zheng, Nanyang Dong, et al., Optimization ultrasonic-assisted aqueous two-phase extraction of glabridin from licorice root and its activity against the foodborne pathogen MRSA, Food Chemistry: X, 2025, 26, 102338.
[33]. Qianwei Qu, Xingyu Huang, Zhan Zhu, Jing Wang, Meiying Zhao, Wenqiang Cui, Yuting Zheng, Yaqing Liu, Xueying Chen, et al., Targeting membrane integrity and imidazoleglycerol-phosphate dehydratase: Sanguinarine multifaceted approach against Staphylococcus aureus biofilms, Phytomedicine, 2025, 138, 156428.
[32]. Natalia Gelfand, Vojtěch Orel, Wenqiang Cui, Jiří Damborský, Chenglong Li, Zbyněk Prokop, Wen Jun Xie, Arieh Warshel, Biochemical and Computational Characterization of Haloalkane Dehalogenase Variants Designed by Generative AI: Accelerating the SN2 Step, Journal of the American Chemical Society, 2025, 147(3), 2747-2755.
[31]. Wenqiang Cui, Shuguang Yuan, Will the hype of automated drug discovery finally be realized?, Expert Opinion on Drug Discovery, 2024, 19(3), 259-262.
[30]. Chunhui Liu, Wenqiang Cui, Kai Zhu, Shuguang Yuan, Lin Sun, Yu Liang, Jian Lu, Dong Li, Zhe Deng, Luyao Duan, et al., Inhibitor screening for volume-sensitive LRRC8A chloride channel, Journal of Biomolecular Structure and Dynamics, 2024, 42(23), 12993-13001.
[29]. Junlin Dong, Shuai Wang, Wenqiang Cui, Xiaolin Sun, Hao Guo, Haotian Yan, Horst Vogel, Zhe Wang, Shuguang Yuan, Machine learning deciphered molecular Mechanistics with accurate kinetic and thermodynamic prediction, Journal of Chemical Theory and Computation, 2024, 20(11), 4499-4513.
[28]. Beatrice Introini, Wenqiang Cui, Xiaowei Chu, Yanyan Zhang, Ana Catarina Alves, Lisa Eckhardt-Strelau, Sebastian Golusik, et al., Structure of tetrameric forms of the serotonin-gated 5-HT3A receptor ion channel, The EMBO Journal, 2024, 43(20), 4451.
[27]. Beimi Cui, Qiaona Pan, Wenqiang Cui, Ying Wang, V. I. P. Loake, Shuguang Yuan, Feng Liu, Gary J. Loake, S-nitrosylation of a receptor-like cytoplasmic kinase regulates plant immunity, Science Advances, 2024, 10(11), eadk3126.
[26]. Haijian Li, Xiaolin Sun, Wenqiang Cui, Marc Xu, Junlin Dong, Babatunde Edukpe Ekundayo, Dongchun Ni, Zhili Rao, Liwei Guo, Henning Stahlberg, Shuguang Yuan, Horst Vogel, Computational drug development for membrane protein targets, Nature Biotechnology, 2024, 42(2), 229-242.
[25]. Chenyang Wu, Marc Xu, Junlin Dong, Wenqiang Cui, Shuguang Yuan, The structure and function of olfactory receptors, Trends in Pharmacological Sciences, 2024, 45(3), 268-280.
[24]. Wenqiang Cui, Junlin Dong, Shiyu Wang, Horst Vogel, Rongfeng Zou, Shuguang Yuan, Molecular basis of ligand selectivity for melatonin receptors, RSC Advances, 2023, 13(7), 4422-4430.
[23]. Tingting Ma, Lin Wang, Anan Chai, Chunhui Liu, Wenqiang Cui, Shuguang Yuan, S. Wing Ngor Au, Lin Sun, et al., Cryo-EM structures of ClC-2 chloride channel reveal the blocking mechanism of its specific inhibitor AK-42, Nature Communications, 2023, 14(1), 3424.
[22]. Qianwei Qu, Wenqiang Cui, Xingyu Huang, Zhan Zhu, Yixian Dong, Zhigang Yuan, Chunhui Dong, Yuting Zheng, Xueying Chen, et al., Gallic Acid Restores the Sulfonamide Sensitivity of Multidrug-Resistant Streptococcus suis via Polypharmaceology Mechanism, Journal of Agricultural and Food Chemistry, 2023, 71(18), 6894-6907.
[21]. Mo Chen, Yan Li, Shuang Li, Wenqiang Cui, Yonghui Zhou, Qianwei Qu, Ruixue Che, Lijun Li, Shuguang Yuan, Xin Liu, Molecular Mechanism of Staphylococcus xylosus Resistance Against Tylosin and Florfenicol, Infection and Drug Resistance, 2022, 15, 6165-6176.
[20]. Lu Zhu, Shiyu Lin, Wenqiang Cui, Yajuan Xu, Lingling Wang, Zhe Wang, Shuguang Yuan, Yiyun Zhang, Ying Fan, et al., A nanomedicine enables synergistic chemo/photodynamic therapy for pancreatic cancer treatment, Biomaterials Science, 2022, 10(13), 3624-3636.
[19]. Shiyu Wang, Xiaolin Sun, Wenqiang Cui, Shuguang Yuan, MM/PB(GB)SA benchmarks on soluble proteins and membrane proteins, Frontiers in Pharmacology, 2022, 13, 1018351.
[18]. Chen Xing, Wen-Qiang Cui, Yue Zhang, Xin-Shu Zou, Jing-You Hao, Sheng-Di Zheng, Ting-Ting Wang, et al., Ultrasound-assisted deep eutectic solvents extraction of glabridin and isoliquiritigenin from Glycyrrhiza glabra: Optimization, extraction mechanism and in vitro bioactivities, Ultrasonics Sonochemistry, 2022, 83, 105946.
[17]. Wenqiang Cui, Fei Yu, Yiyun Zhang, Xue Han, Rongfeng Zou, Yang Tang, Lingling Wang, Nsabimana Eliphaz, Jing Wang, et al., Discovery of traditional Chinese medicines against porcine reproductive and respiratory syndrome virus, Pharmacological Research - Modern Chinese Medicine, 2021, 1, 100003.
[16]. Chun-Liu Dong, Yue Qin, Jin-Xin Ma, Wen-Qiang Cui, Xing-Ru Chen, Li-Ya Hou, Xue-Ying Chen, Bello-Onaghise God’spower, Nsabimana Eliphaz, Jun-Jie Qin, Wen-Xin Guo, Wen-Ya Ding, Yanhua Li, The Active Ingredients Identification and Antidiarrheal Mechanism Analysis of Plantago asiatica L. Superfine Powder, Frontiers in Pharmacology, 2021, 11, 612478.
[15]. Qianwei Qu, Wenqiang Cui, Xiaoxu Xing, Rongfeng Zou, Xingyu Huang, Xiaoting Wang, Tao Wu, Bello-Onaghise God’spower, et al., Rutin, A Natural Inhibitor of IGPD Protein, Partially Inhibits Biofilm Formation in Staphylococcus xylosus ATCC700404 in vitro and in vivo, Frontiers in Pharmacology, 2021, 12, 728354.
[14]. Jing Wang, Qianwei Qu, Xin Liu, Wenqiang Cui, Fei Yu, Xueying Chen, Xiaoxu Xing, Yonghui Zhou, Yu Yang, et al., 1-Hydroxyanthraquinone exhibited antibacterial activity by regulating glutamine synthetase of Staphylococcus xylosus as a virulence factor, Biomedicine & Pharmacotherapy, 2020, 123, 109779.
[13]. Chun-Liu Dong, Sheng-Di Zheng, Yan-Yan Liu, Wen-Qiang Cui, Mei-Qi Hao, Bello-Onaghise God’spower, Xue-Ying Chen, et al., Albendazole solid dispersions prepared using PEG6000 and Poloxamer188: formulation, characterization and in vivo evaluation, Pharmaceutical Development and Technology, 2020, 25(9), 1043-1052.
[12]. Ke Liu, Rongfeng Zou, Wenqiang Cui, Meiqing Li, Xueying Wang, Junlin Dong, Hongchun Li, Hongpei Li, Peihui Wang, Ximing Shao, et al., Clinical HDAC inhibitors are effective drugs to prevent the entry of SARS-CoV2, ACS Pharmacology & Translational Science, 2020, 3(6), 1361-1370.
[11]. Bello-Onaghise God’spower, Guangyi Wang, Xue Han, Eliphaz Nsabimana, Wenqiang Cui, Fei Yu, Yiyun Zhang, et al., Antiviral strategies of Chinese herbal medicine against PRRSV infection, Frontiers in Microbiology, 2020, 11, 1756.
[10]. Wenqiang Cui, Adnane Aouidate, Shouguo Wang, Qiuliyang Yu, Yanhua Li, Shuguang Yuan, Discovering Anti-Cancer Drugs via Computational Methods, Frontiers in Pharmacology, 2020, 11, 733.
[9]. Jing-Wen Bai, Xing-Ru Chen, Yang Tang, Wen-Qiang Cui, Dong-Li Li, Bello-Onaghise God’spower, Yu Yang, Study on microwave assisted extraction of chrysophanol and its intervention in biofilm formation of Streptococcus suis, RSC Advances, 2019, 9(50), 28996-29004.
[8]. Wenqiang Cui, Qian-Wei Qu, Jin-Peng Wang, Jing-Wen Bai, Bello-Onaghise God’spower, Yan-An Li, Yong-Hui Zhou, et al., Discovery of Potential Anti-infective Therapy Targeting Glutamine Synthetase in Staphylococcus xylosus, Frontiers in Chemistry, 2019, 7, 381.
[7]. Qianwei Qu, Jing Wang, Wenqiang Cui, Yonghui Zhou, Xiaoxu Xing, Ruixue Che, Xin Liu, Xueying Chen, et al., In vitro activity and In vivo efficacy of Isoliquiritigenin against Staphylococcus xylosus ATCC 700404 by IGPD target, PLoS One, 2019, 14(12), e0226260.
[6]. Xin Liu, Jing Wang, Mo Chen, Ruixue Che, Wenya Ding, Fei Yu, Yonghui Zhou, Wenqiang Cui, Xiaoxu Xing, et al., Comparative proteomic analysis reveals drug resistance of Staphylococcus xylosus ATCC700404 under tylosin stress, BMC Veterinary Research, 2019, 15(1), 224.
[5]. Yan-Yan Liu, Xing-Ru Chen, Jin-Peng Wang, Wen-Qiang Cui, Xiao-Xu Xing, Xue-Ying Chen, Wen-Ya Ding, et al., Transcriptomic analysis reveals flavonoid biosynthesis of Syringa oblata Lindl. in response to different light intensity, BMC Plant Biology, 2019, 19(1), 487.
[4]. Wen-Ya Ding, Sheng-Di Zheng, Yue Qin, Fei Yu, Jing-Wen Bai, Wen-Qiang Cui, Tong Yu, Xing-Ru Chen, et al., Chitosan grafted with β-cyclodextrin: synthesis, characterization, antimicrobial activity, and role as absorbefacient and solubilizer, Frontiers in Chemistry, 2019, 6, 657.
[3]. Yan-Yan Liu1, Xing-Ru Chen1, Ling-Fei Gao, Mo Chen, Wenqiang Cui, Wen-Ya Ding, Xue-Ying Chen, Bello-Onaghise God’spower, Yanhua Li, Spectrum-Effect Relationships Between the Bioactive Ingredient of Syringa oblata Lindl. Leaves and Its Role in Inhibiting the Biofilm Formation of Streptococcus suis, Frontiers in Pharmacology, 2018, 9, 570.
[2]. Wenya Ding, Yonghui Zhou, Qianwei Qu, Wenqiang Cui, Bello-Onaghise God’spower, Yan-Yan Liu, Xing-Ru Chen, Mo Chen, et al., Azithromycin Inhibits Biofilm Formation by Staphylococcus xylosus and Affects Histidine Biosynthesis Pathway, Frontiers in Pharmacology, 2018, 9, 740.
[1]. Xing-Ru Chen, Xiao-Ting Wang, Mei-Qi Hao, Yong-Hui Zhou, Wen-Qiang Cui, Xiao-Xu Xing, Chang-Geng Xu, Jing-Wen Bai, Yanhua Li, Homology Modeling and Virtual Screening to Discover Potent Inhibitors Targeting the Imidazole Glycerophosphate Dehydratase Protein in Staphylococcus xylosus, Frontiers in Chemistry, 2017, 5, 98.
待补充
[6] 袁曙光，陈显翀，罗木鹏，崔文强，邹荣峰，赵金存，孙静，杆菌酞A在制备预防和治疗冠状病毒的药物中的应用，申请号：CN202010265260.7，授权公告号：CN111420024B，授权公告日：2023.10.03
[5] 袁曙光，崔文强，罗木鹏，邹荣峰，陈显翀，赵金存，孙静，焦谷氨酸在制备预防和治疗抗新冠肺炎新型冠状病毒的药物中的应用，申请号：CN202010266183.7，授权公告号：CN111467338B，授权公告日：2021.04.23
[4] 袁曙光，崔文强，罗木鹏，邹荣峰，陈显翀，赵金存，孙静，膦甲酸钠在制备预防和治疗冠状病毒的药物中的应用，申请号：CN202010265267.9，授权公告号：CN111467355B，授权公告日：2021.04.23
[3] 屈谦伟，崔文强，王金鹏，周永辉，李艳华，索拉非尼在抑菌及干预致病菌生物被膜中的用途，申请号：201811047450.0，授权公告号：CN108785306B，授权公告日：2021.02.19
[2] 屈谦伟，王金鹏，崔文强，于菲，周永辉，邢晓旭，刘鑫，李艳华，1-羟基蒽醌在制备抑菌、干预致病菌生物被膜及治疗奶牛乳房炎的药物中的用途，申请号：ZL201110263589.0，授权公告号：CN108969510B，授权公告日：2021.02.19
[1] 车瑞香，屈谦伟，董春柳，崔文强，王金鹏，周永辉，邢晓旭，李艳华，异甘草素在抑菌、干预生物被膜及治疗奶牛乳房炎中的用途，申请号：CN201811047444.5，授权公告号：CN109200038B，授权公告日：2021.02.12